tiprankstipranks
Trending News
More News >
Elicera Therapeutics AB (DE:8E8)
FRANKFURT:8E8
Germany Market

Elicera Therapeutics AB (8E8) Income Statement

Compare
0 Followers

Elicera Therapeutics AB Income Statement

Last quarter (Q4 2025), Elicera Therapeutics AB's total revenue was kr0.00, a decrease of -100.00% from the same quarter last year. In Q4, Elicera Therapeutics AB's net income was kr-6.97M. See Elicera Therapeutics AB’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
kr 0.00kr 7.13Mkr 11.23Mkr 1.28Mkr 587.00
Gross Profit
kr 0.00kr 7.13Mkr 11.22Mkr 1.28Mkr -11.19K
Operating Expenses
kr 17.94Mkr 24.01Mkr 28.33Mkr 20.64Mkr 13.12M
Depreciation and Amortization
kr 0.00kr 11.79Kkr 11.78Kkr 11.78Kkr 11.78K
EBITDA
kr -17.40Mkr -16.82Mkr -17.09Mkr -19.43Mkr -13.11M
Operating Income
kr -17.94Mkr -16.88Mkr -28.33Mkr -19.36Mkr -13.12M
Other Income/Expenses
kr 538.02Kkr 773.73Kkr 11.93Mkr -75.88Kkr -1.07K
Pretax Income
kr -17.41Mkr -16.11Mkr -16.40Mkr -19.44Mkr -13.12M
Net Income
kr -17.41Mkr -16.11Mkr -16.40Mkr -19.52Mkr -13.12M
Per Share Metrics
Basic EPS
kr -0.38kr -0.51kr -0.83kr -0.98kr -0.82
Diluted EPS
kr -0.38kr -0.51kr -0.83kr -0.98kr -0.82
Weighted Average Shares Outstanding
45.58M 31.57M 19.78M 19.78M 15.94M
Weighted Average Shares Outstanding (Diluted)
48.19M 31.57M 19.78M 19.78M 15.94M
Currency in SEK

Elicera Therapeutics AB Earnings and Revenue History